companydata.dkPerfuseCell Cronus A/S: Financial statements 2018
CVR: 31606810
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 532,018 and a net result of DKK 167,685 compared with DKK 308,579 the year before. That is a decrease of 69.6% compared with the year before. The profit margin was 31.5%. Equity amounted to DKK 490,591. The solvency ratio was 84.4%.
- Revenue
- 532,018 kr.
- Gross Profit
- 271,584 kr.
- Profit/Loss
- 167,685 kr.
- Equity
- 490,591 kr.
- Total Assets
- 581,369 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 532 t. | 272 t. | 168 t. | 491 t. | - |
| 2017 | 1.7 mio. | 310 t. | 309 t. | 323 t. | - |
| 2016 | 0 | 0 | 0 | 14 t. | - |
| 2015 | 0 | 0 | -180 | 14 t. | - |
| 2014 | 0 | 0 | -3 t. | 15 t. | - |
Keep an eye on PerfuseCell Cronus A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
PerfuseCell Cronus A/S has published its annual report for 2017. Revenue came to DKK 1,748,331, and the net result was DKK 308,579.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity amounted to DKK 1,070,836.